News


International Chemical Investors Group to acquire Allessa from Cassella

26. September 2013

International Chemical Investors Group (ICIG) and Casella GmbH have reached an agreement in principle under which ICIG would acquire all of the shares of Allessa GmbH. Both parties have agreed not to disclose the purchase...more


CordenPharma to acquire Peptisyntha from Solvay, expanding peptides custom synthesis business

28. August 2013

International Chemical Investors Group (ICIG) and the Solvay Group have entered into an agreement under which ICIG will acquire Peptisyntha SA, the Brussels, Belgium, based custom manufacturer of peptides for pharmaceutical use....more


RÜTGERS Organics GmbH continues its growth course and acquires the European business of VIANCE

11. July 2013

International Chemical Investors Group, Frankfurt/Main and RÜTGERS Organics, Mannheim, have signed a definitive agreement to acquire the European business of the U.S. wood preservative manufacturer VIANCE. The transaction...more


Tessenderlo Group sells its electrolysis and chloro-aromatics activities in Italy to International Chemical Investors Group

06. May 2013

Tessenderlo Group (NYSE Euronext: TESB) announced today that it has sold Tessenderlo Partecipazioni S.p.A including its subsidiary Tessenderlo Italia Srl to International Chemical Investors Group (ICIG), a private industrial...more


International Chemical Investors Group kicks off €50+ million investment at PPC in Thann

22. March 2013

Membrane-based technology will replace a mercury-based process, enhancing environmental sustainability and increasing competitiveness. PPC, a company of WeylChem Group, the fine chemicals platform of International Chemical...more


Tessenderlo Group has the intention to sell its pharmaceutical ingredients activities to International Chemical Investors Group

09. October 2012

Brussels / Luxembourg – Tessenderlo Group (NYSE Euronext: TESB) announced today that it has the intention to sell its pharmaceutical ingredients activities, Farchemia and Calaire Chimie, to International Chemical Investors Group...more


ICIG acquires Roche’s pharmaceutical manufacturing facility in Boulder, Colorado

04. August 2011

Boulder, CO – The Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and International Chemical Investors Group (ICIG) announced today that they have entered into an agreement for ICIG to acquire Roche Colorado Corporation, which includes...more


International Chemical Investors Group Announces Agreement to Acquire Pharmaceutical Intermediates Business From Genzyme

03. February 2011

Luxembourg – International Chemical Investors Group (ICIG) announced that it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation....more


WeylChem launches WeylChem International

18. January 2011

The Fine Chemicals Platform of International Chemicals Investors (ICIG), WeylChem Group, offers Custom Manufacturing services as well as Advanced Intermediates & Reagents. WeylChem’s manufacturing sites are located in Germany...more


Bristol-Myers Squibb announces the activation of Art. 47 for the Latina Plant

29. March 2010

Latina, March 29, 2010. Bristol-Myers Squibb announced today that will inform the unions that it is commencing the procedures under Art. 47 law no. 428/1990 in connection with the transfer of its manufacturing plant based in...more

Displaying 11 to 20 of 35